key: cord-0817879-10gdedaq authors: Donatin, Emilie; Buffet, Sylvain; Leroy, Quentin; Raoult, Didier; Drancourt, Michel title: A DNA microarray for the versatile diagnosis of infectious diarrhea date: 2013-06-12 journal: APMIS DOI: 10.1111/apm.12081 sha: ae9318d6f328f5801e01c7aea8c6b81503cde03f doc_id: 817879 cord_uid: 10gdedaq Several bacteria, viruses, and parasites cause diarrhea as coinfecting pathogens. We designed a DNA microarray comprising 60‐bp probes spotted 194 times for the multiplex detection of 33 enteropathogenic bacteria and seven enteropathogenic viruses, and the archaeon Methanobrevibacter smithii was used as an internal positive control. Nine pathogen‐free stool specimens were used as negative controls. One of these control specimens was further spiked with Salmonella enterica as a positive control. The microarray was then tested with 40 pathological stool specimens, comprising S. enterica (n = 30), Campylobacter jejuni (n = 4), pathogenic Escherichia coli (n = 2), and adenovirus (n = 4). M. smithii was detected in 47/49 (95.9%) specimens, no pathogen was detected in negative controls and S. enterica was identified in the S. enterica‐spiked positive control. The overall specificity was 100% and the overall sensitivity was 97.5% because one S. enterica sample was missed by the microarray. The multiplexed detection of C. jejuni spiked into an adenovirus‐positive stool sample gave positive results, with fluorescence values of 14.3 and 9.1, respectively. These data indicate that using the protocol developed in this article, the DNA array allows for the multiplexed detection of some enteropathogens in stool samples. Infectious diarrhea is estimated to be the fifth leading cause of death worldwide, with an estimated 2.16 million deaths a year, including 1.5 million pediatric deaths (http://who.int/en/). In France, diarrhea is estimated to generate approximately three million yearly visits to a general practitioner (1) . Pathogens known to be responsible for diarrhea include the bacteria Campylobacter spp. Salmonella spp., Clostridium difficile, pathogenic Escherichia coli, Shigella spp., and Yersinia enterocolitica (2) (http:// www.ecdc.europa.eu/en/Pages/home.aspx). Viruses, including noroviruses, rotaviruses, toroviruses, coronaviruses, astroviruses, enteroviruses, and adenoviruses, reportedly cause 50% of cases of diarrhea (3) . In particular, noroviruses are now the leading cause of diarrhea and enteritis outbreaks worldwide (4, 5) . Routinely, human enteropathogenic bacteria and viruses are searched for separately in different clinical laboratories in hospitals, but coinfections have been reported, particularly in developing countries (6) (7) (8) (9) . Therefore, a multiplex detection approach is warranted to speed diagnosis for the proper treatment and isolation of contagious patients. In addition, such an approach would allow for the detection of clusters and epidemics. A DNA microarray is such a technology for the rapid multiplexed detection of microorganisms in clinical specimens (10) (11) (12) (13) (14) . Accordingly, DNA microarrays have been used to investigate stool microbiota (15) (16) (17) (18) (19) . However, the use of DNA microarrays for the identification of enteropathogenic bacteria in human diarrheal stool specimens has been rarely reported (10, 12, 13, (20) (21) (22) (23) . These microarrays detected a few bacterial pathogens, and few DNA microarrays allowed for the multiplexed detection of pathogens (10) (11) (12) (13) (14) . We therefore customized a DNA microarray for the multiplex detection of 40 bacterial and viral enteropathogens and the archaeon Methanobrevibacter smithii as an internal control, which should be positive in all cases (24) . Nine pathogen-free stool specimens with normal consistency collected from healthy individuals were used as negative controls in all experiments. The control of carriage Staphylococcus aureus in stool is mandatory for some workers in hospital under French law. These stools were used as 'healthy individuals' without diarrhea. One of these control specimens was spiked with 10 8 colony-forming units (CFU)/mL (final concentration) Salmonella enterica CIP 60.62 serotype Typhimurium (Collection de l'Institut Pasteur, Paris, France) in phosphatebuffered saline (PBS) and used as a positive control. Human diarrheal stool specimens routinely submitted to the M editerran ee Infection clinical microbiology laboratory, Marseille, containing S. enterica (n = 30), enteropathogenic Escherichia coli (EPEC) (n = 1), enterohemorrhagic E. coli (EHEC) (n = 1), Campylobacter jejuni (n = 4), and adenoviruses (n = 4) were collected. Bacteria were routinely detected by culture methods, as previously described (2) . Caliciviruses and enteroviruses were routinely detected by a specific real-time PCR method using previously described primers (25, 26) . Rotaviruses were detected by an immunochromatographic assay (Standard Diagnostics, Gurgaon Haryana, India). All of the viruses were further detected by electron microscopy observation. Among these 40 diarrheal stools, no stool specimen was co-infected. No written consent was needed for this work in accordance with the 'LOI n°2004-800 relative a la bio ethique' published in the 'Journal Officiel de la R epublique Franc ßaise' on August 6, 2004 because no additional sample was taken for the study. According to this law, patients were informed that stool specimens could be used for anonymized studies. This study was approved by the local ethics committee of the Institut F ed eratif de Recherche 48, Faculty of Medicine, Marseille, France, reference number 08-002. The archaeon M. smithii was used as an internal positive control, as we previously showed that it was detected in 95.7% of human stool specimens (24) . To choose the 40 pathogens present on our DNA microarray, we based on a recent review of infectious diarrhea (2) . DNA probes were designed on the basis of the 16S rRNA gene sequence for 15 bacterial enteropathogens and specific gene sequences for an additional 13 bacterial enteropathogens as well as for viruses spotted on our microarray (Tables 1 and 2). Among these pathogens, we designed one specific probe for the detection of Grimontia hollisae that is responsible of human diarrhea for people who consumed raw shellfish, especially oysters or more rarely raw or undercooked fish (27) , and Klebsiella oxytoca that is responsible of antibiotic-associated hemorrhagic colitis (AAHC) especially in children (28) . There are unpublished internal evidences of the association between Planctomycetes and the intestinal microbiota (Drancourt M, 2012, unpublished data) , that is why we designed specific probes for the detection of Gemmata obscuriglobus, Pirellula staleyi, Planctomyces brasiliensis/maris, Planctomyces limnophilus, and Rhodopirellula baltica. In particular, five probes were spotted for the detection of pathogenic E. coli: for enterohemorrhagic E. coli (EHEC), we spotted eae and stx1 gene probes (29) ; for enteroinvasive E. coli (EIEC), we spotted ipaB and ipaD gene probes (30) ; for enteropathogenic E. coli (EPEC), we spotted the eae gene probe (31) ; and for Shiga toxinproducing E. coli (STEC), we spotted stx1 and stx2 genes probes (32) . The DNA microarray (Agilent Technologies, Massy, France) comprised eight hybridization arrays containing 15 744 features, each consisting of two interlaced rectangular grids of 96 rows at 0.073323-millimeter spacing by 82 columns at 0.127-millimeter spacing. Each 60-mer probe had an approximately 80°C hybridization temperature. Each probe was spotted 194 times on each hybridization array. Diarrheal stools were lyophilized before DNA extraction. Briefly, stool specimens were freeze-dried for 24 h in 1-mL glass containers (Dominique Dustcher, Brumath, France) in the same lyophilizer with the negative control stool specimen. After lyophilization, stool specimens were regenerated in 250 lL PBS, resulting in a four-fold concentration of the diarrheal stool specimens. Lyophilized specimens were then manipulated in parallel with non-diarrheal stool specimens, which were not lyophilized. Instead, one gram of non-diarrheal stool specimen was diluted into 5 mL PBS and vortexed with 3-mm glass beads (Dominique Dustcher) for 30 s. In total, 250 lL of (Table 3) The Genomic DNA ULS Labeling Kit TM and the ULS-Cy TM 3 reagent were used according to the To test the capacity of the DNA microarray to simultaneously detect several pathogens in one stool specimen, we collected a stool sample that was naturally infected by adenovirus. An aliquot of this stool specimen was spiked with 10 4 -10 6 CFU/mL (final concentration) C. jejuni CIP 70.2 in PBS. The DNA extraction protocol used in this article yielded 41 AE 28 ng/mL total DNA. M. smithii DNA was detected in the nine negative control stool specimens (Ct mean value, 30.14), in the stool sample spiked with S. enterica (Ct value, 34.18) and in the 40 pathological stools (Ct values, 21.18 to 31.23). S. enterica DNA was not detected in the negative control stool specimens, but it was detected in the stool sample spiked with S. enterica (Ct value, 19.46). Thirty S. enterica-infected diarrheal stools were lyophilized before DNA extraction. The real-time PCR detection of S. enterica was positive in all specimens, with Ct values between 24.31 and 29.47. S. enterica was not detected in the remaining ten pathological stool specimens. Regarding pathogenic E. coli, none of the five targets were detected in the negative controls or the positive control. The ipaB gene was detected in one pathological stool infected with C. jejuni (Ct value, 32.61). One pathological stool sample infected with EPEC was positive for the stx1 gene (Ct value, 22.78). The stx2 gene was detected in two pathological stools infected with C. jejuni (Ct values, 29.08 and 33.40, respectively). The ipaD and eae genes were negative for all stool samples tested. Four adenovirus-contaminated stool specimens yielded Ct values between 16.43 and 21.68; adenovirus was not detected in the other pathological stools or control stools. Four C. jejuni-infected pathological stool specimens yielded positive results for fla and wlaC genes, while the negative and positive controls and the remaining pathological stool specimens were negative. The M. smithii internal control was detected in 47/49 (95.9%) stool specimens tested, with fluorescence signals between 9 and 14.5 units. Twenty-nine of 30 (96.7%) S. enterica-infected pathological stool specimens yielded 194 positive S. enterica-specific probes, with fluorescence signals between 9 and 11.1; no other pathogen was detected in the 30 specimens, and S. enterica was not detected in the remaining stool specimens. The pathological stool specimen infected with EPEC yielded 194 positive stx1 gene probes, with a mean fluorescence value >10 units. The pathological stool contaminated with EHEC yielded 178 positive eae gene probes, with a mean fluorescence value of 10.4 units. The ipaB probe was positive in 13/47 (27.7%) remaining stools without a pathogenic E. coli. The nine control stools and the 38 remaining pathological stools were negative for all probes specific for pathogenic E. coli. Four C. jejuni-contaminated pathological stool specimens yielded 132 positive probes, with a mean fluorescence of 9.1 in all specimens; the remaining specimens were negative for C. jejuni. Four adenovirus-infected pathological stool specimens yielded positive detection, with fluorescence values between 9.1 and 10.9, and the remaining specimens were negative for adenovirus. One of these pathological stools infected with adenovirus and spiked with C. jejuni yielded a positive detection of 10 5 and 10 6 C. jejuni CFU/ mL with fluorescence values of 14.3 for adenovirus and 11.9 and 12.1 for C. jejuni, respectively; the 10 4 CFU/mL inoculum was not detected. The results here obtained in a clinical microbiology laboratory, were interpreted as valid because all the negative controls remained negative in all of the experiments. In addition, DNA microarray data were controlled in parallel with real-time PCR, including the detection of M. smithii DNA as an internal positive control. Indeed, we previously showed that this archaeal DNA was detected in 95.7% of individuals (24) , making this archaeon a suitable target to control for total DNA extraction and the absence of PCR inhibition in extracted stool specimens. Detecting M. smithii DNA was further used to confirm that the dilution of diarrheal stool specimens did not prevent the DNAbased detection of pathogens. In this study, we lyophilized diarrheal stools as lyophilization has previously been used to suppress PCR inhibition in animal stool specimens (36, 37) . We therefore recommend lyophilizing diarrheal stool specimens before detecting enteropathogenic DNA. The DNA microarray reported in this article allowed for the simplex detection of enteropathogens in stool, with a sensitivity of 97.5%. However, detecting pathogenic E. coli was problematic. We designed probes based on published virulence genes reported to be specific for each pathogenic E. coli. EIEC strains were detected with ipaB and ipaD probes (30) . IpaB is a gene encoding an invasion protein found in not only E. coli strains but also Shigella and Salmonella strains. This gene is known to be specific for these strains (38) , but we found that our ipaB probe gave positive results for 13/47 (27.7%) stool samples tested. This result may be due to a lack of specificity of the probe despite our favorable in silico analysis. Alternatively, this observation could be explained by the fact that this gene is much more ubiquitous than previously reported. For example, only 6% of genes are common between all E. coli strains, which are called the core genome (39) , and in fact, we do not really know the virulence genes that can reliably identify strains of E. coli. Intestinal infections could be caused by several pathogens at the same time, but the simultaneous detection of enteric bacteria and viruses has never been performed using a DNA microarray. Developing a protocol for the multiplex detection of human enteric pathogens was challenging, but our data indicate that it is possible to achieve the multiplexed detection of some enteropathogens. Previously reported DNA microarrays allowed for the detection of only a few bacteria (12, 13, 20) . Regarding viruses, DNA chips have allowed for the detection of the rotaviruses A group (40) (41) (42) (43) . In 2009, a DNA microarray was designed for the detection of common foodborne viruses, including human rotaviruses (44) ; however, this system was not adapted for the diagnosis of human acute enteritis. No DNA microarray has been published for the dual detection of viral and bacterial enteropathogens. Our data confirm the proof-of-concept of multiplex detection for enteric pathogens using a DNA microarray. Further studies will aim to reduce the turn-over time, which was 3 h in this study. The DNA microarray technique is amenable to automation and could be used for epidemiological studies and the selection of stool specimens devoid of any known pathogen for further investigations using additional approaches. The cost of DNA microarray remains a negative point as this technique in our laboratory is estimated at about 130 € per sample. In addition, a more complete version of the DNA microarray could be used for the repertoire of the gut microbiota using the protocol developed in this study. Epid emiologie des maladies transmissibles en m edecine g en erale lib erale: bilan du r eseau Sentinelles en 1995 Acute Diarrhea Epidemiology of infectious acute diarrhea in France and Europe Noroviruses: a comprehensive review Viral gastroenteritis associated with genogroup II Norovirus among U.S. military personnel in Turkey Isolation and genetic characterization of a coinfection of non-O157 shiga toxin-producing Escherichia coli Coinfection of viral agents in Korean children with acute watery diarrhea Diarrhea-associated biofilm formed by enteroaggregative Escherichia coli and aggregative Citrobacter freundii: a consortium mediated by putative F pili Global study of viral diarrhea in hospitalized children in Spain: Results of Structural Surveillance of Viral Gastroenteritis Net Work (VIGESS-net) Detection and identification of intestinal pathogens in clinical specimens using DNA microarrays Simultaneous detection of six human diarrheal pathogens by using DNA microarray combined with tyramide signal amplification A novel DNA microarray for rapid diagnosis of enteropathogenic bacteria in stool specimens of patients with diarrhea Detection of representative enteropathogenic bacteria, Vibrio spp., pathogenic Escherichia coli, Salmonella spp., Shigella spp., and Yersinia enterocolitica, using a virulence factor gene-based oligonucleotide microarray Development of an oligonucleotide-based microarray to detect multiple foodborne pathogens Molecular analysis of the bacterial microbiota in the human stomach Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults High taxonomic level fingerprint of the human intestinal microbiota by ligase detection reaction-universal array approach Optimizing the analysis of human intestinal microbiota with phylogenetic microarray Design and evaluation of oligonucleotidemicroarray method for the detection of human intestinal bacteria in fecal samples DNA microarray analysis of predominant human intestinal bacteria in fecal samples Development of a serotype-specific DNA microarray for identification of some Shigella and pathogenic Escherichia coli strains High-throughput quantitative analysis of the human intestinal microbiota with a phylogenetic microarray High prevalence of Methanobrevibacter smithii and Methanosphaera stadmanae detected in the human gut using an improved DNA detection protocol Rapid diagnosis of enterovirus infections by real-time PCR on the Light Cycler using the Taqman format Detection and characterization of norovirus outbreaks in Germany: application of a one-tube RT-PCR using a fluorogenic real-time detection system Grimontia hollisae, a potential agent of gastroenteritis and bacteraemia in the Mediterranean area Antibiotic-associated hemorrhagic colitis caused by cytotoxin-producing Klebsiella oxytoca Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes Single multiplex PCR assay to identify simultaneously the six categories of diarrheagenic Escherichia coli associated with enteric infections Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR Isolation of DNA from bacterial samples of the human gastrointestinal tract Evaluation of methods for subtyping Campylobacter jejuni during an outbreak involving a food handler DNA diversity of the wla gene cluster among serotype HS:19 and non-HS:19 Campylobacter jejuni strains Lyophilization improves the extraction of PCR-quality community DNA from pig faecal samples Lyophilization prior to detect direct DNA extraction from bovine feces improves the quantification of Escherichia coli O157:H7 and Campylobacter jejuni The evolutionary history of Shigella and Enteroinvasive Escherichia coli revised Comparison of 61 sequenced Escherichia coli genomes Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization Microarrays for genotyping human group A rotavirus by multiplex capture and type-specific primer extension Development and validation of DNA microarray for genotyping group A Rotavirus VP4 Development and validation of a microarray for the confirmation and typing of Norovirus RT-PCR products A microarray based approach for the identification of common foodborne viruses